Metabolism
Serine/threonine kinase AMPK upregulates glucose uptake by promoting the expression and function of glucose transporters. AMPK is activated by increased AMP/ATP ratio, resulting from cellular and environmental stress, e.g. low glucose, heat shock, hypoxia and ischemia. AMPK activation positively modulates signaling transductions that refill ATP levels. Moreover, it also stimulates catabolic processes such as fatty acid oxidation and glycolysis through inhibition of ACC and activation of PFK2. AMPK negatively regulates various proteins which are important to ATP-consuming mechanisms, e.g. mTORC2, glycogen synthase, SREBP-1, and TSC2, causing the downregulation/inhibition of gluconeogenesis and glycogen, lipid and protein synthesis.
-
B5562 TC-F 2Summary: FAAH inhibitor
-
B5704 SA 57Summary: FAAH inhibitor
-
B5714 SA 47Summary: FAAH inhibitor
-
B4931 TAK 21dSummary: Potent FAAH inhibitor
-
B7356 PF 750Summary: FAAH inhibitor
-
B7701 JZL 195Summary: Dual inhibitor of fatty acid amide hydrolase (FAAH) and monoacylglycerol lipase (MAGL)
-
C5619 N-BenzylpalmitamideSummary: inhibitor of fatty acid amide hydrolase (FAAH)
-
C5452 Monoacylglycerol Lipase Inhibitor 21Summary: inhibitor of monoacylglycerol lipase (MAGL) and FAAH
-
C5719 Oleyl Trifluoromethyl KetoneSummary: potent inhibitor of FAAH